XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Wondering about your retirement target at 40? Discover how to plan ahead for a secure financial future with our expert insights.
24,965 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Beyond Meat faces headwinds, but a protein drinks turnaround catalyst could change the game. This article breaks down...
As Ethereum’s core stewardship rethinks its mission, Vitalik Buterin advocates a leaner, more opinionated foundation....
The House Ways and Means Committee plans a June hearing to decide if crypto tax relief should cover more than stablec...
Whirlpool’s scale appliance demand is a telling gauge of how households spend on big-ticket upgrades. As the housing ...
Vertiv rode a powerful wave in February as AI-driven data-center demand accelerated and the company highlighted durab...
A senior Iranian official publicly mocks Trump's appeal to help reopen the Hormuz Strait as tensions intensify, with ...
Five major loan-channel partnerships in five days are redefining how borrowers learn about and secure loans. The rapi...
Former Goldman Sachs CEO Lloyd Blankfein warns that AI operates with speed but limited verifiability, a risk that cou...
Institutional money flows into Bitcoin and Ethereum spur a new wave of adoption, while Solana, XRP, and Chainlink gro...
Schg’s 32× start melt-up is shaping a pivotal market moment: can a growth-heavy ETF sustain gains on high valuations,...
Visa and Mastercard posted stronger-than-expected Q1 results as cross-border spending rebounds. The key question for ...